Atherosclerosis

Heart-shaped diamond
Biotech

Former Pfizer antibody reduces cardio risk marker in ph. 2

Pacibekitug, an antibody Tourmaline licensed from Pfizer in 2022, reduced levels of C-reactive protein in patients with chronic kidney disease.
Darren Incorvaia May 20, 2025 7:30am
heart valentines day valentine puzzle merger MA

Repair licenses Genevant's tech for up to $107M per product

Sep 26, 2024 2:53pm
heart coronary artery cardiovascular scan MRI

Chasing Merck, AstraZeneca's PCSK9 inhibitor lowers cholesterol

May 29, 2024 11:00am
arrow target quiver aim shoot ammo

Arrowhead's cholesterol drug hits the mark again in ph. 2 trial

May 28, 2024 9:13am
An artists depiction of a heart with a clogged artery

AstraZeneca drug once tested for cancer slows atherosclerosis

Jun 9, 2023 7:40am
uproot tree

Bitterroot Bio emerges from stealth with $145M series A

Jun 7, 2023 8:00am